Projects per year
Fingerprint
Dive into the research topics where Christian Rolfo is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Targeting CD38 in HIV-associated Lymphoma
Owonikoko, T. K. (PI), Alexander, H. R. (CoPI), Ambulos, N. P. (CoPI), Antalis, T. M. (CoPI), Tomkinson, A. E. (CoPI), Baer, M. R. (CoPI), Bentzen, S. M. (CoPI), Burger, A. M. (CoPI), Cao, X. (CoPI), Carter, J. (CoPI), Davila, E. (CoPI), Dorgan, J. F. (CoPI), Duong, V. H. (CoPI), Emadi, A. (CoPI), Fan, X. (CoPI), Rassool, F. (CoPI), Fulton, A. M. (CoPI), Gullapalli, R. P. (CoPI), Ioffe, O. B. (CoPI), Cullen, K. J. (CoPI), Kleinberg, M. E. (CoPI), Knott, C. L. (CoPI), Lapidus, R. G. (CoPI), Livak, F. (CoPI), Long, S. W. (CoPI), Mao, L. (CoPI), Martin, S. S. (CoPI), Mishra, M. (CoPI), Rapoport, A. P. (CoPI), Rolfo, C. (CoPI), Sausville, E. A. (CoPI), Tan, M. T. (CoPI), Weber, D. J. (CoPI) & Weber, D. S. (CoPI)
08/8/08 → 08/31/25
Project: Research
-
First in Human Phase I/II clinical trial of ONC-392: Preserving CTLA-4 immune tolerance checkpoint for safer and more effective cancer immunotherapy
Zheng, P. (PI), He, K. K. (CoPI), Rolfo, C. (CoPI), Li, T. T. (CoPI) & Zheng, P. (CoPI)
04/3/20 → 03/31/23
Project: Research
-
Early Phase Clinical Research Support
Sausville, E. A. (PI) & Rolfo, C. (PI)
08/1/16 → 07/31/21
Project: Research
-
Clinical characteristics of EGFR-ctDNA shedders in EGFR-mutant NSCLC patients
Ruglioni, M., Petrini, I., Crucitta, S., Sbrana, A., Luculli, G. I., Sadeghi Gol, L., Forte, C., Chella, A., Rolfo, C., Danesi, R. & Del Re, M., Feb 2025, In: Translational Oncology. 52, 102228.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
CLO25-053: Real-World Evidence of Survival in Patients With Metastatic NSCLC Treated With First-Line Immune Checkpoint Inhibitors Beyond Progression
Johns, N., Rudich, A., Zhao, S., Chian, K., Su, P. L., Khorasanchi, A., Gheeya, J., Spakowicz, D., Wei, L., Roof, L., Alahmadi, A., Memmott, R., Kauffman, J., Presley, C., He, K., Shields, P. G., Rolfo, C., Carbone, D. P., Owen, D. & Li, M., Mar 28 2025, In: Journal of the National Comprehensive Cancer Network : JNCCN. 23, 35Research output: Contribution to journal › Article › peer-review
-
CLO25-080: Outcomes of Extreme Low PD-L1 Expression in Advanced Non-Small Cell Lung Cancer: Implications for Treatment Approaches
Rudich, A., Johns, N., Zhao, S., Chian, K., Su, P. L., Khorasanchi, A., Gheeya, J., Spakowicz, D., Wei, L., Roof, L., Alahmadi, A., Memmott, R., Kauffman, J., Presley, C., He, K., Shields, P. G., Rolfo, C., Carbone, D. P., Li, M. & Owen, D., Mar 28 2025, In: Journal of the National Comprehensive Cancer Network : JNCCN. 23, 35Research output: Contribution to journal › Article › peer-review
-
CNPY2 in Solid Tumors: Mechanisms, Biomarker Potential, and Therapeutic Implications
Mullick Chowdhury, S., Hong, F., Rolfo, C., Li, Z., He, K., Wesolowski, R., Mortazavi, A. & Meng, L., Feb 2025, In: Biology. 14, 2, 214.Research output: Contribution to journal › Review article › peer-review
Open Access -
Efficacy and Safety of Bintrafusp Alfa, a Bifunctional Fusion Protein Targeting Transforming Growth Factor-β and Programmed Death-Ligand 1, Plus Chemotherapy in Patients With Stage IV NSCLC
Rolfo, C., Greillier, L., Veillon, R., Badin, F., Ghiringhelli, F., Isambert, N., Paulus, A., Chaudhary, S. P., Vugmeyster, Y., Sato, M. & Hiret, S., Jan 2025, In: JTO Clinical and Research Reports. 6, 1, 100748.Research output: Contribution to journal › Article › peer-review
Open Access